Evidence map›Paper›PMID 21152935›Full record

ArticleHuman genetics2011

Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18.

Keiko Koide, Donna K Slonim, Kirby L Johnson, Umadevi Tantravahi, Janet M Cowan, Diana W Bianchi

Abstract read
In one paragraph

Article in Human genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A Framework for Understanding Maternal Immunity.Immunology and allergy clinics of North America · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Article
  17. The pathway not taken: understanding 'omics data in the perinatal context.American journal of obstetrics and gynecology · 2015
    Article
  18. CSAX: Characterizing Systematic Anomalies in eXpression Data.Journal of computational biology : a journal of computational molecular cell biology · 2015
    Article
  19. Article
  20. The amniotic fluid transcriptome as a guide to understanding fetal disease.Cold Spring Harbor perspectives in medicine · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Keiko KoideDivision of Genetics, Department of Pediatrics, Floating Hospital for Children at Tufts Medical Center, 800 Washington Street, Box 394, Boston, MA 02111, USA.
Donna K Slonim
Kirby L Johnson
Umadevi Tantravahi
Janet M Cowan
Diana W Bianchi
Tufts Medical Center · USProvidence College · USTufts Children's Hospital · USTufts University · US

Funding

Feto-Maternal DNA/RNA Trafficking:Biology &ApplicationsR01HD042053 · NICHD · TUFTS MEDICAL CENTER · PI BIANCHI, DIANA W. · 2004 to 2013
$3.2M
Translational Bioinformatics for Human Developmental GenomicsR01HD058880 · NICHD · TUFTS UNIVERSITY MEDFORD · PI SLONIM, DONNA K. · 2009 to 2012
$1.3M
NICHD NIH HHS R01 HD042053NICHD NIH HHS R01 HD 042053-07NICHD NIH HHS R01 HD058880NICHD NIH HHS R01 HD 058880-01
6 · The paper itself

Abstract

Trisomy 18 is a common human aneuploidy that is associated with significant perinatal mortality. Unlike the well-characterized "critical region" in trisomy 21 (21q22), there is no corresponding region on chromosome 18 associated with its pathogenesis. The high morbidity and mortality of affected individuals has limited extensive investigations. In order to better understand the molecular mechanisms underlying the congenital anomalies observed in this condition, we investigated the in utero gene expression profile of second trimester fetuses affected with trisomy 18. Total RNA was extracted from cell-free amniotic fluid supernatant from aneuploid fetuses and euploid controls matched for gestational age and hybridized to Affymetrix U133 Plus 2.0 arrays. Individual differentially expressed transcripts were obtained by two-tailed t tests. Over-represented functional pathways among these genes were identified with DAVID and Ingenuity(®) Pathways Analysis. Results show that three hundred and fifty-two probe sets representing 251 annotated genes were statistically significantly differentially expressed between trisomy 18 and controls. Only 7 genes (2.8% of the annotated total) were located on chromosome 18, including ROCK1, an up-regulated gene involved in valvuloseptal and endocardial cushion formation. Pathway analysis indicated disrupted function in ion transport, MHCII/T cell mediated immunity, DNA repair, G-protein mediated signaling, kinases, and glycosylation. Significant down-regulation of genes involved in adrenal development was identified, which may explain both the abnormal maternal serum estriols and the pre and postnatal growth restriction in trisomy 18. Comparison of this gene set to one previously generated for trisomy 21 fetuses revealed only six overlapping differentially regulated genes. This study contributes novel information regarding functional developmental gene expression differences in fetuses with trisomy 18.

Indexed as

TrisomyAdrenal GlandsAlgorithmsChromosomes, Human, Pair 18DNA RepairDown-RegulationEndocardial CushionsEstriolFemaleGene Expression ProfilingGlycosylationGTP-Binding ProteinsHumansImmunity, CellularIon TransportMolecular Sequence AnnotationEstriolGTP-Binding Proteinsrho-Associated KinasesROCK1 protein, human

Identifiers

PMID21152935
PMCPMC3206603
OpenAlexW2091077369

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.